The Association of Marital Status With Kidney Cancer Surgery Morbidity
1 other identifier
observational
106,752
0 countries
N/A
Brief Summary
Retrospective cohort study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2003
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2018
CompletedFirst Submitted
Initial submission to the registry
August 31, 2022
CompletedFirst Posted
Study publicly available on registry
September 2, 2022
CompletedSeptember 6, 2022
September 1, 2022
15.3 years
August 31, 2022
September 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
surgical complications
Complication rates were based on the Clavien-Dindo classification of surgical complications and divided into four categories: no complications, minor complications (Clavien grades 1, 2), and non-fatal major complications (Clavien grades 3, 4), and mortality (Clavien grade 5).
90 days after surgery
Secondary Outcomes (2)
patient disposition
90 days after surgery
readmission rates
90 days after surgery
Eligibility Criteria
The study cohort was also limited to adult patients (age \>= 18 years), "elective" cases based on administrative codes, as well as surgery on hospital day zero or one to minimize outlier patients who could skew the surgical outcomes.
You may qualify if:
- Surgery was performed for a kidney mass.
- age \>= 18 years
- "elective" cases
- Surgery was performed on the day0 or day1 after administration.
You may not qualify if:
- ICD codes are not available.
- Missing value of the primary outcomes and exposure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Tsinghua Chang Gung Hospitallead
- Brigham and Women's Hospitalcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Attending
Study Record Dates
First Submitted
August 31, 2022
First Posted
September 2, 2022
Study Start
January 1, 2003
Primary Completion
March 31, 2018
Study Completion
March 31, 2018
Last Updated
September 6, 2022
Record last verified: 2022-09